cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Boston Scientific Corp
34 own
34 watching
Current Price
$67.45
$-0.51
(-0.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
81,759.25M
52-Week High
52-Week High
69.21000
52-Week Low
52-Week Low
48.35000
Average Volume
Average Volume
2.75M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
56.3277
iconMarket Capitalization81,759.25M
icon52-Week High69.21000
icon52-Week Low48.35000
iconAverage Volume2.75M
iconDividend Yield--
iconP/E Ratio56.3277
What does the Boston Scientific Corp do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Read More
How much money does Boston Scientific Corp make?
News & Events about Boston Scientific Corp.
PR Newswire
9 months ago
Boston Scientific Announces Conference Call Discussing Second Quarter 2023 Results Boston Scientific Announces Conference Call Discussing Second Quarter 2023 Results PR Newswire MARLBOROUGH, Mass., June 28, 2023 MARLBOROUGH, Mass., June 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE...
ValueWalk
10 months ago
Key Points You generally associate Super Bowl commercials with products made by PepsiCo Inc. (NYSE:PEP) or the Coca-Cola Co. (NYSE:KO), ... Read more Key Points Dexcom is aiming for growth, and this year showcased its G7 sensors in a Super Bowl commercial. The companys stock recently cleared a ...
Accesswire
10 months ago
NORTHAMPTON, MA / ACCESSWIRE / June 14, 2023 / At Boston Scientific, we encourage everyone to bring their full selves to work, knowing they'll be accepted, heard and valued.For Pride Month, three employees from around the globe share what having a supportive and inclusive culture means to them, and...
Accesswire
11 months ago
NORTHAMPTON, MA / ACCESSWIRE / May 1, 2023 / Boston Scientific The winners of this year's awards Each day, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of people around the world. Boston Scientific was recently recognized by the...
TipRanks Financial Blog
11 months ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Boston Scientific (BSX Research Report), Humana ... Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Boston Scientific (BSX Research Report), Humana...
Frequently Asked Questions
Frequently Asked Questions
What is Boston Scientific Corp share price today?
plus_minus_icon
Can Indians buy Boston Scientific Corp shares?
plus_minus_icon
How can I buy Boston Scientific Corp shares from India?
plus_minus_icon
Can Fractional shares of Boston Scientific Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Boston Scientific Corp stocks?
plus_minus_icon
What is today’s traded volume of Boston Scientific Corp?
plus_minus_icon
What is today’s market capitalisation of Boston Scientific Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Boston Scientific Corp?
plus_minus_icon
What percentage is Boston Scientific Corp down from its 52-Week High?
plus_minus_icon
What percentage is Boston Scientific Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$67.45
$-0.51
(-0.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Penumbra Inc
Penumbra Inc
$201.90
$-6.78 (-3.25 %)
Stryker Corporation
Stryker Corporation
$327.58
$-8.45 (-2.51 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$233.15
$0.94 (0.40 %)
Baxter International Inc.
Baxter International Inc.
$39.67
$0.15 (0.38 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Penumbra Inc
Penumbra Inc
$201.90
$-6.78 (-3.25 %)
Stryker Corporation
Stryker Corporation
$327.58
$-8.45 (-2.51 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$233.15
$0.94 (0.40 %)
Baxter International Inc.
Baxter International Inc.
$39.67
$0.15 (0.38 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00